Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Market Analysis & Valuation

UpdatedApr 04, 2026
DataAggregated Company Financials
Companies131
  • 7D4.2%
  • 3M-11.2%
  • 1Y-13.7%
  • YTD-11.2%

The market is up 4.2% in the last 7 days, led by the Healthcare and all sectors gaining ground. Over the past year the market is down 14%. Earnings are forecast to grow by 8.7% annually.

Trending IndustriesBiotech

Market Valuation and Performance

Has the Danish Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 05 Apr 2026DKK 3.7tDKK 2.0tDKK 237.6b15.3x15.7x1.9x
Tue, 03 Mar 2026DKK 3.8tDKK 2.0tDKK 237.8b16.7x15.9x1.9x
Thu, 29 Jan 2026DKK 4.5tDKK 1.9tDKK 260.3b16.8x17.2x2.3x
Sat, 27 Dec 2025DKK 4.2tDKK 1.9tDKK 260.5b16.2x16x2.1x
Mon, 24 Nov 2025DKK 3.9tDKK 2.0tDKK 262.5b14.8x14.9x2x
Wed, 22 Oct 2025DKK 4.2tDKK 1.9tDKK 287.8b15.1x14.4x2.1x
Fri, 19 Sep 2025DKK 4.1tDKK 1.9tDKK 287.0b15.3x14.5x2.2x
Sun, 17 Aug 2025DKK 3.9tDKK 1.9tDKK 280.3b14.8x13.8x2x
Tue, 15 Jul 2025DKK 4.4tDKK 1.9tDKK 262.0b15.8x16.8x2.4x
Thu, 12 Jun 2025DKK 4.8tDKK 1.9tDKK 263.0b15.8x18.4x2.6x
Sat, 10 May 2025DKK 4.4tDKK 1.9tDKK 266.9b15.1x16.3x2.3x
Mon, 07 Apr 2025DKK 4.1tDKK 1.9tDKK 260.3b13x15.8x2.2x
Wed, 05 Mar 2025DKK 5.3tDKK 1.9tDKK 263.2b13.8x20x2.8x
Fri, 31 Jan 2025DKK 5.2tDKK 1.8tDKK 238.1b14.1x21.7x2.8x
Sun, 29 Dec 2024DKK 5.3tDKK 1.8tDKK 238.2b13.9x22.4x2.9x
Tue, 26 Nov 2024DKK 5.8tDKK 1.8tDKK 237.6b14.6x24.5x3.2x
Thu, 24 Oct 2024DKK 6.1tDKK 1.7tDKK 180.2b15.2x33.7x3.5x
Sat, 21 Sep 2024DKK 6.4tDKK 1.7tDKK 180.0b16.1x35.5x3.7x
Mon, 19 Aug 2024DKK 6.6tDKK 1.7tDKK 180.2b16.8x36.8x3.8x
Wed, 17 Jul 2024DKK 6.8tDKK 1.7tDKK 185.3b15.6x36.9x4x
Fri, 14 Jun 2024DKK 7.0tDKK 1.7tDKK 184.7b15.5x37.7x4.1x
Sun, 12 May 2024DKK 6.5tDKK 1.7tDKK 183.8b14.7x35.1x3.8x
Tue, 09 Apr 2024DKK 6.4tDKK 1.7tDKK 192.3b15x33.2x3.7x
Thu, 07 Mar 2024DKK 6.3tDKK 1.7tDKK 191.8b13.2x32.7x3.7x
Sat, 03 Feb 2024DKK 6.0tDKK 1.8tDKK 225.0b14.1x26.5x3.3x
Mon, 01 Jan 2024DKK 5.5tDKK 1.8tDKK 216.0b14.2x25.7x3.1x
Wed, 29 Nov 2023DKK 5.3tDKK 1.8tDKK 216.1b13.2x24.7x3x
Fri, 27 Oct 2023DKK 5.2tDKK 1.9tDKK 284.4b12.4x18.3x2.8x
Sun, 24 Sep 2023DKK 5.3tDKK 1.9tDKK 283.7b13.1x18.6x2.8x
Tue, 22 Aug 2023DKK 5.3tDKK 1.9tDKK 281.2b13.3x18.7x2.8x
Thu, 20 Jul 2023DKK 5.0tDKK 1.9tDKK 318.4b13.4x15.8x2.6x
Sat, 17 Jun 2023DKK 5.2tDKK 1.9tDKK 322.1b13.8x16x2.7x
Mon, 15 May 2023DKK 5.3tDKK 1.9tDKK 322.8b14.2x16.5x2.8x
Wed, 12 Apr 2023DKK 4.9tDKK 1.9tDKK 343.9b15x14.2x2.6x
Price to Earnings Ratio

14.2x


Total Market Cap: DKK 4.9tTotal Earnings: DKK 343.9bTotal Revenue: DKK 1.9tTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Market Price to Earnings3Y Average 22.4x202420252026
Current Market PE
  • Investors are pessimistic on the Danish market, indicating that they anticipate earnings will not grow as fast as they have historically.
  • The market is trading at a PE ratio of 15.7x which is lower than its 3-year average PE of 22.4x.
Past Earnings Growth
  • The earnings for Danish listed companies have declined 12% per year over the last three years.
  • Meanwhile revenues have been flat.
  • This means that either the cost of doing business or the level of investment back into businesses is increasing since sales have remained steady while profits have fallen.

Sector Trends

Which sectors have driven the changes within the Danish Market?

DK Market4.17%
Utilities10.70%
Tech9.62%
Financials4.87%
Consumer Discretionary4.35%
Industrials3.85%
Healthcare3.69%
Consumer Staples2.82%
Energy1.94%
Materials1.91%
Telecom1.16%
Real Estate0.39%
Sector PE
  • Investors favour the Utilities sector the most for future growth which is trading above its 3-year average PE ratio.
    • This is likely because analysts are expecting annual earnings growth of 23.0% and investors are willing to pay a premium for that growth.
  • The Consumer Discretionary sector is the least preferred by investors for future growth, which is trading below its 3-year average of 17.5x.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 37% over the next 5 years.
  • This is better than its past earnings decline of 36% per year.
  • In contrast, the Energy sector is expected to see its earnings decline by 16% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
NOVO B Novo NordiskDKK 236.903.7%
+DKK 37.0b		-45.2%PE10.3xHealthcare
ORSTED ØrstedDKK 158.2510.7%
+DKK 20.2b		-43.8%PE121.1xUtilities
DSV DSVDKK 1.58k5.2%
+DKK 18.6b		33.6%PE44.6xIndustrials
DANSKE Danske BankDKK 319.005.9%
+DKK 14.3b		64.3%PB1.4xFinancials
VWS Vestas Wind SystemsDKK 186.456.0%
+DKK 10.5b		114.8%PE31.6xIndustrials
See more

Market Insights

Header cover image
What’s happening with Renewables & EVs?
Richard Bowman avatar
Richard Bowman
Part 1 of 3 in our “What’s happening with…” series, where we look back on the investment themes that were all the rage just a few years ago and see how they're doing now.
Continue reading
How to spot the winners in 2026's IPOs

Latest News

DANSKE
DKK 319.00
Danske Bank
7D
5.9%
1Y
64.3%

DANSKE: Future Returns Will Depend On Executing Buybacks And Dividend Plans

Danske Bank's analyst price target has moved higher, with the fair value estimate shifting from DKK 234.54 to DKK 317.17 as analysts factor in updated assumptions around slightly lower revenue growth, a small uplift in profit margin, and a higher future P/E multiple. Analyst Commentary Recent research on Danske Bank has generally featured higher price targets, but the tone is not uniformly upbeat.
NKT
DKK 866.50
NKT
7D
8.3%
1Y
98.0%

NKT: Elevated Expectations Will Face Growing Execution Risk On Major Projects

Analysts have lifted the fair value estimate for NKT to about DKK 522 per share from roughly DKK 435, citing updated assumptions for revenue growth, profit margins and future P/E levels, in light of recent price target changes including JPMorgan's move to DKK 752 and fresh downgrades from other houses. Analyst Commentary Recent research paints a mixed picture around NKT, with some high profile houses lifting price targets while several bearish analysts have turned more cautious.
NOVO B
DKK 236.90
Novo Nordisk
7D
3.7%
1Y
-45.2%

NOVO B: Future Returns Will Rely On Weekly Diabetes And Obesity Treatments

Narrative Update: Novo Nordisk Price Target Shift The analyst price target for Novo Nordisk has been adjusted slightly higher to DKK 309.77 from DKK 309.63. This reflects updated analyst assumptions that incorporate revised revenue growth, profit margin and future P/E inputs.
VWS
DKK 186.45
Vestas Wind Systems
7D
6.0%
1Y
114.8%

VWS: Execution Risks Will Undermine Optimistic Margin And Order Delivery Assumptions

Analysts have nudged their DKK fair value estimate for Vestas Wind Systems to about DKK 97 per share, supported by recent price target increases to DKK 185 at Morgan Stanley, higher Street expectations for profit margins, and a lower forward P/E, even as views remain mixed after both upgrades and downgrades in recent weeks. Analyst Commentary Recent Street research on Vestas Wind Systems reflects a split view, with some firms lifting price targets and others turning more cautious.
STENO
DKK 1.06
Stenocare
7D
-8.2%
1Y
199.4%
GMAB
DKK 1,758.50
Genmab
7D
4.5%
1Y
40.5%

GMAB: 2026 Late Stage Oncology Catalysts Will Support Stronger Margin Profile

Genmab's updated analyst price target now sits at DKK 3,017, a modest reset from DKK 3,060 as analysts factor in higher discount rates, revised long term margin expectations, and recent research that reflects both increased revenue growth assumptions and a lower future P/E multiple. Analyst Commentary Recent Street research around Genmab has centered on how new clinical and portfolio developments filter into valuation, with several bullish analysts updating price targets and investment cases to reflect revised expectations on execution and long term growth potential.
STRINV
DKK 0.67
Strategic Investments
7D
-2.2%
1Y
-32.0%
DSV
DKK 1,576.00
DSV
7D
5.2%
1Y
33.6%

DSV: Schenker Synergies And 2026 Guidance Will Support Stronger Earnings Power

DSV's analyst price targets have edged higher, with recent upward revisions of up to DKK 414 as analysts adjust fair value assumptions slightly, including a marginally higher projected profit margin and P/E multiple. Analyst Commentary Recent research updates cluster around higher price targets for DSV, with several banks adjusting their fair value assumptions and published target ranges.
KONSOL
DKK 5.65
Konsolidator
7D
-2.6%
1Y
65.2%
MAERSK B
DKK 16,005.00
A.P. Møller - Mærsk
7D
-0.6%
1Y
66.7%
NSIS B
DKK 387.30
Novozymes
7D
1.9%
1Y
-5.2%
ORSTED
DKK 158.25
Ørsted
7D
10.7%
1Y
-43.8%
GJ
DKK 73.00
Glunz & Jensen Holding
7D
-2.7%
1Y
7.4%
DAC
DKK 3.68
Danish Aerospace
7D
-13.2%
1Y
-62.4%
FYNBK
DKK 190.00
Fynske Bank
7D
-1.0%
1Y
37.7%
NLFSK
DKK 138.20
Nilfisk Holding
7D
-1.1%
1Y
77.0%